Linagliptin improves endothelial function in patients with type 2 diabetes: A randomized study of linagliptin effectiveness on endothelial function

Aims/Introduction The present multicenter, prospective, controlled, open and randomized three‐arm parallel study was designed to compare the effects of linagliptin with those of metformin on endothelial function. Materials and Methods Type 2 diabetes patients treated with 750 mg of metformin (hemogl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of diabetes investigation 2017-05, Vol.8 (3), p.330-340
Hauptverfasser:	Shigiyama, Fumika, Kumashiro, Naoki, Miyagi, Masahiko, Iga, Ryo, Kobayashi, Yuka, Kanda, Eiichiro, Uchino, Hiroshi, Hirose, Takahisa
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Apolipoprotein B Apolipoproteins Cardiovascular Diseases - complications Cardiovascular Diseases - drug therapy Clinical Trial Diabetes Diabetes mellitus Diabetes Mellitus, Type 2 - complications Endothelial function Female Hemoglobin Humans Hyperglycemia Hypoglycemic Agents - therapeutic use Linagliptin Linagliptin - therapeutic use Low density lipoprotein Male Metformin Metformin - therapeutic use Middle Aged Prospective Studies Treatment Outcome Type 2 diabetes
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims/Introduction The present multicenter, prospective, controlled, open and randomized three‐arm parallel study was designed to compare the effects of linagliptin with those of metformin on endothelial function. Materials and Methods Type 2 diabetes patients treated with 750 mg of metformin (hemoglobin A1c ≥6.0% and
ISSN:	2040-1116 2040-1124
DOI:	10.1111/jdi.12587